Gemini Therapeutics, Inc. ($GMTX)
Filing Information
| Accession Number | 0001193125-26-055630 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 18, 2026 |
| Document Date | Feb 17, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
3,256
Total Value
$204,672.16
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Feb 17, 2026 | Sale | 3,256 | $62.86 | $204,672.16 | 92,589 | Direct | โ | View Details |